The syndicate banks are led by the Joint Global Coordinators, Credit Suisse First Boston and UBS Warburg. They will allocate 4,500,000 Syngenta shares (in the form of shares or ADSs) to institutional investors worldwide in the Global Secondary Offering. Following the commencement of trading, the Joint Global Co-ordinators will procure the shares in the Global Secondary Offering either by purchasing Syngenta shares in the open market, or by exercising all or part of the option granted to them by certain Novartis affiliates and related entities.

Syngenta intends to implement in the first ten trading days the repurchase of up to 10% of its issued share capital, in full. Syngenta intends to commence the repurchase programme at the earlier of (i) such time as the managers of the Global Secondary Offering have covered their short position by purchasing in the market Syngenta shares distributed to AstraZeneca shareholders, or (ii) on the fourth day of trading. This will be subject to market conditions and all applicable laws and regulations in the relevant jurisdictions, and at the discretion of the Syngenta board. The share repurchase will be funded by Novartis and AstraZeneca.